Telmisartan Intermediate CAS 152628-02-9 Purity >99.0% (HPLC) Factory
Ruifu Chemical Supply Telmisartan Intermediates With High Purity
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl)benzoic Acid CAS 7148-03-0
Telmisartan Benzimidazole Acid CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Chemical Name | 2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole |
Synonyms | 1,7'-Dimethyl-2'-Propyl-2,5'-Bibenzimidazole; 4-Methyl-6-(1-Methylbenzimidazol-2-yl)-2-Propylbenzimidazole; Telmisartan Related Compound A USP; Telmisartan EP Impurity A |
CAS Number | 152628-02-9 |
CAT Number | RF-PI1882 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C19H20N4 |
Molecular Weight | 304.40 |
Melting Point | 130.0~135.0℃ |
Density | 1.23±0.10 g/cm3 |
Solubility | Soluble in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Off-White to Light Yellow Crystalline Powder |
Solubility | Clean Solution Without Precipitate |
Water Content (K.F) | <6.50% |
Sulphated Ash | <0.30% |
Related Substances | |
Any Individual Impurity | <0.50% |
Total Impurities | <1.00% |
Assay (By Chemical) | >99.0% (On Dried Basis) |
Infrared Spectrum | Conforms to Structure |
NMR | Conforms to Structure |
Test Standard | Enterprise Standard |
Usage | Intermediate of Telmisartan (CAS: 144701-48-4) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole (CAS: 152628-01-8) is an intermediate of Telmisartan (CAS: 144701-48-4). Telmisartan is an angiotensin II receptor used to treat hypertension. Most blood pressure lowering drugs currently have a maximum effect of 10 hours. Telmisartan is the most powerful drug of its kind. Clinical studies have shown that Telmisartan can reduce blood pressure 24 hours a day, including early morning, when cardiovascular disease is at its highest risk. Telmisartan is also currently the only one kind of angiotensin receptor blockers, confirmed by clinical research in addition to high blood pressure in patients with cardiovascular risk and diabetes patients, can provide additional cardiovascular protection, reduce their death due to cardiovascular disease, myocardial infarction, or stroke.